MaghrebDataLibMedV2, Main, Merge, bibRecord, 000358

Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

Identifieur interne : 000358 ( Main/Merge ); précédent : 000357; suivant : 000359

Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

Auteurs : Khalid El Bairi [Maroc] ; Abdul Hafeez Kandhro [Pakistan] ; Adel Gouri [Algérie] ; Wafaa Mahfoud [Maroc] ; Noureddine Louanjli [Maroc] ; Brahim Saadani [Maroc] ; Said Afqir [Maroc] ; Mariam Amrani [Maroc]

Source :

Cellular oncology (Dordrecht) [ 2211-3436 ] ; 2017.

RBID : pubmed:27981507

Descripteurs français

KwdFr :
- Cellules tumorales circulantes (anatomopathologie), Femelle (MeSH), Humains (MeSH), Marqueurs biologiques tumoraux (sang), Modèles biologiques (MeSH), Pronostic (MeSH), Tumeurs de l'ovaire (anatomopathologie), Tumeurs de l'ovaire (diagnostic), Tumeurs de l'ovaire (génétique), Tumeurs de l'ovaire (thérapie), Épigenèse génétique (MeSH).
MESH :
- anatomopathologie : Cellules tumorales circulantes, Tumeurs de l'ovaire.
- diagnostic : Tumeurs de l'ovaire.
- génétique : Tumeurs de l'ovaire.
- sang : Marqueurs biologiques tumoraux.
- thérapie : Tumeurs de l'ovaire.
- Femelle, Humains, Modèles biologiques, Pronostic, Épigenèse génétique.

English descriptors

KwdEn :
- Biomarkers, Tumor (blood), Epigenesis, Genetic (MeSH), Female (MeSH), Humans (MeSH), Models, Biological (MeSH), Neoplastic Cells, Circulating (pathology), Ovarian Neoplasms (diagnosis), Ovarian Neoplasms (genetics), Ovarian Neoplasms (pathology), Ovarian Neoplasms (therapy), Prognosis (MeSH).
MESH :
- chemical , blood : Biomarkers, Tumor.
- diagnosis : Ovarian Neoplasms.
- genetics : Ovarian Neoplasms.
- pathology : Neoplastic Cells, Circulating, Ovarian Neoplasms.
- therapy : Ovarian Neoplasms.
- Epigenesis, Genetic, Female, Humans, Models, Biological, Prognosis.

Abstract

BACKGROUND

In spite of various treatment options currently available, ovarian cancer (OC) still remains a leading cause of death in women world-wide. Diagnosis at an early stage is one of the most important factors that determines survival. Current clinical diagnostic tools have, however, a limited efficacy in early OC detection. Therefore, there is a critical need for new (early) diagnostic biomarkers and tools. Through advances in genomic, proteomic and metabolomic techniques, several novel molecular OC biomarkers have recently been identified. These biomarkers are currently subject to validation. In addition, integration of genomic, proteomic and metabolomic data, in conjunction with epidemiologic and clinical data, is considered essential for obtaining useful results. Interesting recent work has already shown that specific diagnostic biomarkers, such as BRCA mutations, may have profound therapeutic implications. Here, we review the current state of OC research through literature and database searches, with a focus on various recently identified biomarkers via different technologies for the (early) diagnosis, prognosis and treatment of OC.

CONCLUSIONS

Multi-biomarker panels accompanied by a meticulous determination of their sensitivity and specificity, as well their validation, using multivariate analyses will be critical for its clinical application, including early OC detection and tailor-made OC treatment.

DOI: 10.1007/s13402-016-0309-1
PubMed: 27981507

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000457
to stream PubMed, to step Curation: 000456
to stream PubMed, to step Checkpoint: 000434

Links to Exploration step

pubmed:27981507

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.</title>
<author><name sortKey="El Bairi, Khalid" sort="El Bairi, Khalid" uniqKey="El Bairi K" first="Khalid" last="El Bairi">Khalid El Bairi</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine and Pharmacy, Oujda, Morocco. k.elbairi@ump.ac.ma.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Faculty of Medicine and Pharmacy, Oujda</wicri:regionArea>
<wicri:noRegion>Oujda</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Independent Research Team in Cancer Biology and Bioactive Compounds, Mohammed 1st University, Oujda, Morocco. k.elbairi@ump.ac.ma.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Independent Research Team in Cancer Biology and Bioactive Compounds, Mohammed 1st University, Oujda</wicri:regionArea>
<wicri:noRegion>Oujda</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kandhro, Abdul Hafeez" sort="Kandhro, Abdul Hafeez" uniqKey="Kandhro A" first="Abdul Hafeez" last="Kandhro">Abdul Hafeez Kandhro</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biochemistry, Healthcare Molecular and Diagnostic Laboratory, Hyderabad, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Department of Biochemistry, Healthcare Molecular and Diagnostic Laboratory, Hyderabad</wicri:regionArea>
<wicri:noRegion>Hyderabad</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gouri, Adel" sort="Gouri, Adel" uniqKey="Gouri A" first="Adel" last="Gouri">Adel Gouri</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratory of Medical Biochemistry, Ibn Rochd University Hospital, Annaba, Algeria.</nlm:affiliation>
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>Laboratory of Medical Biochemistry, Ibn Rochd University Hospital, Annaba</wicri:regionArea>
<wicri:noRegion>Annaba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mahfoud, Wafaa" sort="Mahfoud, Wafaa" uniqKey="Mahfoud W" first="Wafaa" last="Mahfoud">Wafaa Mahfoud</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratory of Biology and Health, URAC-34, Faculty of Science Ben Msik, University Hassan II, Mohammedia, Casablanca, Morocco.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Laboratory of Biology and Health, URAC-34, Faculty of Science Ben Msik, University Hassan II, Mohammedia, Casablanca</wicri:regionArea>
<wicri:noRegion>Casablanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Louanjli, Noureddine" sort="Louanjli, Noureddine" uniqKey="Louanjli N" first="Noureddine" last="Louanjli">Noureddine Louanjli</name>
<affiliation wicri:level="1"><nlm:affiliation>Labomac IVF Centers and Clinical Laboratory Medicine, Casablanca, Morocco.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Labomac IVF Centers and Clinical Laboratory Medicine, Casablanca</wicri:regionArea>
<wicri:noRegion>Casablanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Saadani, Brahim" sort="Saadani, Brahim" uniqKey="Saadani B" first="Brahim" last="Saadani">Brahim Saadani</name>
<affiliation wicri:level="1"><nlm:affiliation>IVF center IRIFIV, Clinique des Iris, Casablanca, Morocco.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>IVF center IRIFIV, Clinique des Iris, Casablanca</wicri:regionArea>
<wicri:noRegion>Casablanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Afqir, Said" sort="Afqir, Said" uniqKey="Afqir S" first="Said" last="Afqir">Said Afqir</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Mohamed 1st University Hospital, Oujda, Morocco.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Department of Medical Oncology, Mohamed 1st University Hospital, Oujda</wicri:regionArea>
<wicri:noRegion>Oujda</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Amrani, Mariam" sort="Amrani, Mariam" uniqKey="Amrani M" first="Mariam" last="Amrani">Mariam Amrani</name>
<affiliation wicri:level="3"><nlm:affiliation>Equipe de Recherche ONCOGYMA, Faculty of Medicine, Pathology Department, National Institute of Oncology, Université Mohamed V, Rabat, Morocco.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Equipe de Recherche ONCOGYMA, Faculty of Medicine, Pathology Department, National Institute of Oncology, Université Mohamed V, Rabat</wicri:regionArea>
<placeName><settlement type="city">Rabat</settlement>
<region nuts="2">Rabat-Salé-Kénitra</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:27981507</idno>
<idno type="pmid">27981507</idno>
<idno type="doi">10.1007/s13402-016-0309-1</idno>
<idno type="wicri:Area/PubMed/Corpus">000457</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000457</idno>
<idno type="wicri:Area/PubMed/Curation">000456</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000456</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000434</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000434</idno>
<idno type="wicri:Area/Main/Merge">000358</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.</title>
<author><name sortKey="El Bairi, Khalid" sort="El Bairi, Khalid" uniqKey="El Bairi K" first="Khalid" last="El Bairi">Khalid El Bairi</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine and Pharmacy, Oujda, Morocco. k.elbairi@ump.ac.ma.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Faculty of Medicine and Pharmacy, Oujda</wicri:regionArea>
<wicri:noRegion>Oujda</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Independent Research Team in Cancer Biology and Bioactive Compounds, Mohammed 1st University, Oujda, Morocco. k.elbairi@ump.ac.ma.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Independent Research Team in Cancer Biology and Bioactive Compounds, Mohammed 1st University, Oujda</wicri:regionArea>
<wicri:noRegion>Oujda</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kandhro, Abdul Hafeez" sort="Kandhro, Abdul Hafeez" uniqKey="Kandhro A" first="Abdul Hafeez" last="Kandhro">Abdul Hafeez Kandhro</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biochemistry, Healthcare Molecular and Diagnostic Laboratory, Hyderabad, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Department of Biochemistry, Healthcare Molecular and Diagnostic Laboratory, Hyderabad</wicri:regionArea>
<wicri:noRegion>Hyderabad</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gouri, Adel" sort="Gouri, Adel" uniqKey="Gouri A" first="Adel" last="Gouri">Adel Gouri</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratory of Medical Biochemistry, Ibn Rochd University Hospital, Annaba, Algeria.</nlm:affiliation>
<country xml:lang="fr">Algérie</country>
<wicri:regionArea>Laboratory of Medical Biochemistry, Ibn Rochd University Hospital, Annaba</wicri:regionArea>
<wicri:noRegion>Annaba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mahfoud, Wafaa" sort="Mahfoud, Wafaa" uniqKey="Mahfoud W" first="Wafaa" last="Mahfoud">Wafaa Mahfoud</name>
<affiliation wicri:level="1"><nlm:affiliation>Laboratory of Biology and Health, URAC-34, Faculty of Science Ben Msik, University Hassan II, Mohammedia, Casablanca, Morocco.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Laboratory of Biology and Health, URAC-34, Faculty of Science Ben Msik, University Hassan II, Mohammedia, Casablanca</wicri:regionArea>
<wicri:noRegion>Casablanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Louanjli, Noureddine" sort="Louanjli, Noureddine" uniqKey="Louanjli N" first="Noureddine" last="Louanjli">Noureddine Louanjli</name>
<affiliation wicri:level="1"><nlm:affiliation>Labomac IVF Centers and Clinical Laboratory Medicine, Casablanca, Morocco.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Labomac IVF Centers and Clinical Laboratory Medicine, Casablanca</wicri:regionArea>
<wicri:noRegion>Casablanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Saadani, Brahim" sort="Saadani, Brahim" uniqKey="Saadani B" first="Brahim" last="Saadani">Brahim Saadani</name>
<affiliation wicri:level="1"><nlm:affiliation>IVF center IRIFIV, Clinique des Iris, Casablanca, Morocco.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>IVF center IRIFIV, Clinique des Iris, Casablanca</wicri:regionArea>
<wicri:noRegion>Casablanca</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Afqir, Said" sort="Afqir, Said" uniqKey="Afqir S" first="Said" last="Afqir">Said Afqir</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Oncology, Mohamed 1st University Hospital, Oujda, Morocco.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Department of Medical Oncology, Mohamed 1st University Hospital, Oujda</wicri:regionArea>
<wicri:noRegion>Oujda</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Amrani, Mariam" sort="Amrani, Mariam" uniqKey="Amrani M" first="Mariam" last="Amrani">Mariam Amrani</name>
<affiliation wicri:level="3"><nlm:affiliation>Equipe de Recherche ONCOGYMA, Faculty of Medicine, Pathology Department, National Institute of Oncology, Université Mohamed V, Rabat, Morocco.</nlm:affiliation>
<country xml:lang="fr">Maroc</country>
<wicri:regionArea>Equipe de Recherche ONCOGYMA, Faculty of Medicine, Pathology Department, National Institute of Oncology, Université Mohamed V, Rabat</wicri:regionArea>
<placeName><settlement type="city">Rabat</settlement>
<region nuts="2">Rabat-Salé-Kénitra</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Cellular oncology (Dordrecht)</title>
<idno type="eISSN">2211-3436</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biomarkers, Tumor (blood)</term>
<term>Epigenesis, Genetic (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Models, Biological (MeSH)</term>
<term>Neoplastic Cells, Circulating (pathology)</term>
<term>Ovarian Neoplasms (diagnosis)</term>
<term>Ovarian Neoplasms (genetics)</term>
<term>Ovarian Neoplasms (pathology)</term>
<term>Ovarian Neoplasms (therapy)</term>
<term>Prognosis (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Cellules tumorales circulantes (anatomopathologie)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Marqueurs biologiques tumoraux (sang)</term>
<term>Modèles biologiques (MeSH)</term>
<term>Pronostic (MeSH)</term>
<term>Tumeurs de l'ovaire (anatomopathologie)</term>
<term>Tumeurs de l'ovaire (diagnostic)</term>
<term>Tumeurs de l'ovaire (génétique)</term>
<term>Tumeurs de l'ovaire (thérapie)</term>
<term>Épigenèse génétique (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Biomarkers, Tumor</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Cellules tumorales circulantes</term>
<term>Tumeurs de l'ovaire</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Tumeurs de l'ovaire</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Tumeurs de l'ovaire</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Neoplastic Cells, Circulating</term>
<term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Marqueurs biologiques tumoraux</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Tumeurs de l'ovaire</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Epigenesis, Genetic</term>
<term>Female</term>
<term>Humans</term>
<term>Models, Biological</term>
<term>Prognosis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Femelle</term>
<term>Humains</term>
<term>Modèles biologiques</term>
<term>Pronostic</term>
<term>Épigenèse génétique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b>
</p>
<p>In spite of various treatment options currently available, ovarian cancer (OC) still remains a leading cause of death in women world-wide. Diagnosis at an early stage is one of the most important factors that determines survival. Current clinical diagnostic tools have, however, a limited efficacy in early OC detection. Therefore, there is a critical need for new (early) diagnostic biomarkers and tools. Through advances in genomic, proteomic and metabolomic techniques, several novel molecular OC biomarkers have recently been identified. These biomarkers are currently subject to validation. In addition, integration of genomic, proteomic and metabolomic data, in conjunction with epidemiologic and clinical data, is considered essential for obtaining useful results. Interesting recent work has already shown that specific diagnostic biomarkers, such as BRCA mutations, may have profound therapeutic implications. Here, we review the current state of OC research through literature and database searches, with a focus on various recently identified biomarkers via different technologies for the (early) diagnosis, prognosis and treatment of OC.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>Multi-biomarker panels accompanied by a meticulous determination of their sensitivity and specificity, as well their validation, using multivariate analyses will be critical for its clinical application, including early OC detection and tailor-made OC treatment.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27981507</PMID>
<DateCompleted><Year>2017</Year>
<Month>03</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2211-3436</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>40</Volume>
<Issue>2</Issue>
<PubDate><Year>2017</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Cellular oncology (Dordrecht)</Title>
<ISOAbbreviation>Cell Oncol (Dordr)</ISOAbbreviation>
</Journal>
<ArticleTitle>Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.</ArticleTitle>
<Pagination><MedlinePgn>105-118</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s13402-016-0309-1</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In spite of various treatment options currently available, ovarian cancer (OC) still remains a leading cause of death in women world-wide. Diagnosis at an early stage is one of the most important factors that determines survival. Current clinical diagnostic tools have, however, a limited efficacy in early OC detection. Therefore, there is a critical need for new (early) diagnostic biomarkers and tools. Through advances in genomic, proteomic and metabolomic techniques, several novel molecular OC biomarkers have recently been identified. These biomarkers are currently subject to validation. In addition, integration of genomic, proteomic and metabolomic data, in conjunction with epidemiologic and clinical data, is considered essential for obtaining useful results. Interesting recent work has already shown that specific diagnostic biomarkers, such as BRCA mutations, may have profound therapeutic implications. Here, we review the current state of OC research through literature and database searches, with a focus on various recently identified biomarkers via different technologies for the (early) diagnosis, prognosis and treatment of OC.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Multi-biomarker panels accompanied by a meticulous determination of their sensitivity and specificity, as well their validation, using multivariate analyses will be critical for its clinical application, including early OC detection and tailor-made OC treatment.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El Bairi</LastName>
<ForeName>Khalid</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Faculty of Medicine and Pharmacy, Oujda, Morocco. k.elbairi@ump.ac.ma.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Independent Research Team in Cancer Biology and Bioactive Compounds, Mohammed 1st University, Oujda, Morocco. k.elbairi@ump.ac.ma.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kandhro</LastName>
<ForeName>Abdul Hafeez</ForeName>
<Initials>AH</Initials>
<AffiliationInfo><Affiliation>Department of Biochemistry, Healthcare Molecular and Diagnostic Laboratory, Hyderabad, Pakistan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gouri</LastName>
<ForeName>Adel</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Laboratory of Medical Biochemistry, Ibn Rochd University Hospital, Annaba, Algeria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mahfoud</LastName>
<ForeName>Wafaa</ForeName>
<Initials>W</Initials>
<AffiliationInfo><Affiliation>Laboratory of Biology and Health, URAC-34, Faculty of Science Ben Msik, University Hassan II, Mohammedia, Casablanca, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Louanjli</LastName>
<ForeName>Noureddine</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Labomac IVF Centers and Clinical Laboratory Medicine, Casablanca, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Saadani</LastName>
<ForeName>Brahim</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>IVF center IRIFIV, Clinique des Iris, Casablanca, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Afqir</LastName>
<ForeName>Said</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Medical Oncology, Mohamed 1st University Hospital, Oujda, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Amrani</LastName>
<ForeName>Mariam</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Equipe de Recherche ONCOGYMA, Faculty of Medicine, Pathology Department, National Institute of Oncology, Université Mohamed V, Rabat, Morocco.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>12</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Cell Oncol (Dordr)</MedlineTA>
<NlmUniqueID>101552938</NlmUniqueID>
<ISSNLinking>2211-3428</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009360" MajorTopicYN="N">Neoplastic Cells, Circulating</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarkers</Keyword>
<Keyword MajorTopicYN="N">Circulating tumor cells</Keyword>
<Keyword MajorTopicYN="N">Diagnosis</Keyword>
<Keyword MajorTopicYN="N">Epigenetics</Keyword>
<Keyword MajorTopicYN="N">Ovarian cancer</Keyword>
<Keyword MajorTopicYN="N">Prognosis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>12</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>12</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>12</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27981507</ArticleId>
<ArticleId IdType="doi">10.1007/s13402-016-0309-1</ArticleId>
<ArticleId IdType="pii">10.1007/s13402-016-0309-1</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Science. 2010 Sep 17;329(5998):1492-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20847263</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Cancer. 2015 Mar 1;136(5):E359-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25220842</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Ovarian Res. 2014 Jan 25;7:14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24460816</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Mol Genet. 2014 Apr 1;23 (7):1894-906</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24256813</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Oncol (Dordr). 2014 Feb;37(1):9-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24249155</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Genet. 2012 Oct;13(10):679-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22945394</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cancer Res. 2015 Mar;13(3):393-401</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25304686</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cancer Res Ther. 2016 Apr-Jun;12 (2):498-508</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27461600</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2014 Feb;132(2):462-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24374023</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Carcinogenesis. 2014 Sep;35(9):2113-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24925027</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Oncol. 2012 Oct;23 Suppl 7:vii20-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22997450</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Genome Res. 2013 May;23(5):843-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23382536</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Cancer. 2011 Mar 1;104(5):863-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21304524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Genes Chromosomes Cancer. 2010 Jul;49(7):577-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20461750</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Rev Oncol Hematol. 2012 Dec;84(3):314-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22575381</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oncotarget. 2011 Dec;2(12):1265-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22246208</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Res. 2012 Aug 15;72(16):4141-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22617326</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Cytopathol. 2014 Sep;122(9):685-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24888238</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Endocr Relat Cancer. 2010 Dec 21;18(1):85-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21051560</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Cancer Res Clin Oncol. 2010 Jul;136(7):1079-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20082099</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Oncol. 2011 Mar;12(3):273-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21345725</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Ther. 2012 May;20(5):960-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22314290</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(9):e44960</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22970327</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Semin Cell Dev Biol. 2012 Jun;23 (4):352-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22406683</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):E4978-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24297935</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Pathol. 2013 Apr;182(4):1391-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23499052</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2013 Jul;130(1):12-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23578540</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Pathol. 2010 Sep;177(3):1053-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20651229</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Cancer. 2011 Mar 27;11:108</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21439085</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Cancer Res. 2015 Oct 15;5(11):3363-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26807317</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Oncol (Dordr). 2012 Jun;35(3):181-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22581446</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Gynecol Cancer. 2011 May;21(4):625-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21412167</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Oncol. 2012 Feb 1;30(4):372-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22203755</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Oncol. 2012 Dec;6(6):590-610</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23102669</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>IARC Sci Publ. 2011;(162):257-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21675431</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pathol Oncol Res. 2011 Sep;17(3):511-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21207255</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Natl Cancer Inst. 2010 Feb 24;102(4):211-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20110550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Gynecol Cancer. 2016 Nov;26(9):1586-1593</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27540691</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Clin Invest. 2010 Jul;40(7):591-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20482593</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2011 Oct 30;17(11):1498-503</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22037646</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2011;6(5):e19963</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21625518</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Oncol. 2014 Feb 20;32(6):579-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24449238</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oncol Rep. 2015 Jun;33(6):2915-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25962395</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2016 Jul;142(1):199-205</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27058839</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2010 Dec 3;330(6009):1340-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21127244</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Endocrinology. 2012 Apr;153(4):1593-602</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22416079</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oncogene. 2015 Jul;34(27):3605-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25263447</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Oncol (Dordr). 2012 Dec;35(6):473-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23055343</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Cancer Res. 2016 May 01;6(5):973-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27293992</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2012 Dec 18;157(12 ):900-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22964825</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Mol Sci. 2016 May 18;17 (5):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27213343</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Oncol. 2013 Feb;14 (2):134-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23261356</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Oncol (Dordr). 2016 Oct;39(5):397-410</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27126599</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Cancer Res. 2016 Sep 15;22(18):4664-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27060155</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2011 Mar 4;144(5):646-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21376230</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Ovarian Res. 2013 Jul 02;6(1):45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23819707</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Surg Pathol. 2010 Mar;34(3):433-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20154587</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2014 May;133(2):362-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24607283</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Oncol. 2014 Jan;15(1):23-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24314615</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Gynaecol Oncol. 2011;32(5):516-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22053665</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):119-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21632171</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Gynecol Pathol. 2010 May;29(3):203-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20407318</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2012 Mar;124(3):582-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22115852</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Obstet Gynaecol. 2014 Oct;34(7):620-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24911418</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Oncol (Dordr). 2017 Feb;40(1):97-103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27761889</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2016 Mar 5;387(10022):945-956</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26707054</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Cancer. 2016 Jan;53:51-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26693899</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer. 2015 Jul 1;121(13):2108-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25820366</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Biol Regul. 2015 Jan;57:1-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25294678</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2011 Jun 29;474(7353):609-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21720365</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cancer. 2016 Jun 24;15(1):48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27343009</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2013 Nov 01;8(11):e77853</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24223734</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Cancer. 2016 Jun 15;138(12):2984-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26815306</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oncotarget. 2015 Aug 28;6(25):21100-19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26053184</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2011 Jun 8;305(22):2295-303</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21642681</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Exp Med Biol. 2015;867:229-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26530369</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Genes Chromosomes Cancer. 2015 Jan;54(1):1-19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25280227</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Cancer. 2014 Feb 18;110(4):976-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24366298</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Obstet Fertil. 2015 May;43(5):335-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25824714</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Biochem Sci. 2016 Mar;41(3):211-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26778478</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Biochem. 2016 Jan;49(1-2):32-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26285075</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Toxicol Pathol. 2012 Oct;40(7):1049-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22581811</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2013 Jan;128(1):15-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23017820</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Cancer. 2010 Dec 03;10 :666</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21129172</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2016 Jul;142(1):144-149</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27106017</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Pathol. 2014;9:27-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23937438</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Natl Cancer Inst. 2013 Jan 16;105(2):141-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23257159</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Cell Int. 2013 Aug 27;13(1):86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23978303</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Asian Pac J Cancer Prev. 2014;15(6):2719-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24761891</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Cancer. 2011 Sep 21;11:399</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21933447</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Cancer. 2013 Apr;13(4):273-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23426401</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Oncol. 2010 May 1;28(13):2159-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20368574</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Pathol. 2016 Apr;186(4):733-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27012190</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Oncol. 2012 Sep;23 Suppl 10:x111-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22987944</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Cancer Res. 2014 Feb 1;20(3):764-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24240112</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virchows Arch. 2012 Mar;460(3):237-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22322322</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oncol Rep. 2013 Jul;30(1):3-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23660957</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(4):e34653</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22506041</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Mol Sci. 2013 Jul 30;14(8):15885-909</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23903048</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Lett. 2015 Jan 28;356(2 Pt B):628-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25451316</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Oncol (Dordr). 2016 Aug;39(4):295-318</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27060060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2014 Mar 27;157(1):95-109</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24679529</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lab Chip. 2015 Jun 7;15(11):2388-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25940789</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Cancer. 2010 Apr 13;102(8):1244-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20354523</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):2995-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20962299</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Commun. 2011 Feb 01;2:180</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21285958</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Oncol. 2014 Jun 12;4:144</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24971229</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Surg Oncol. 2016 Dec;42(12 ):1772-1779</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27265041</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Diagn Ther. 2013 Jun;17(3):139-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23552992</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Traffic. 2011 Dec;12(12):1659-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21645191</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2016 Jul;142(1):176-183</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27058837</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Metastasis. 2010 Mar;27(3):185-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20229256</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Gynecol Cancer. 2013 May;23(4):673-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23542579</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Endocr Relat Cancer. 2014 Jan 30;21(2):217-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24273235</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell. 2014 Jun 5;54(5):716-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24905005</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Res. 2010 Feb 15;70(4):1668-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20124479</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Cell. 2012 Jul 10;22(1):9-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22789535</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Prev Res (Phila). 2015 Jan;8(1):37-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25388014</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2013 Nov;19(11):1438-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24202396</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Cancer. 2011 Jun 1;128(11):2527-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21365651</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Obstet Gynecol. 2011 Jun;117(6):1298-306</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21555961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Genes Genet Syst. 2016 Nov 26;91(3):175-181</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27452040</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Oncol. 2012 Dec;29(4):2937-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22274916</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pathol. 2010 May;221(1):49-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20229506</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Oncol (Dordr). 2015 Feb;38(1):17-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25113790</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26742998</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEBS Lett. 2011 Jul 7;585(13):2112-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21402071</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18622-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20926745</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2010 Mar;116(3):378-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19945742</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Cancer. 2010 Aug 24;103(5):693-700</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20683447</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gynecol Oncol. 2012 Jul;23(3):175-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22808360</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2015 Aug 21;10(8):e0136419</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26295337</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Genet Genomic Med. 2015 Mar;3(2):121-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25802882</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2013 Jul;130(1):107-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23558050</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2010 Jun 15;5(6):e11137</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20559444</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Oncol (Dordr). 2016 Feb;39(1):47-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26510945</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Pathol. 2016 Jul;186(7):1724-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27338107</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2012 Jul 6;150(1):12-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22770212</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Obstet Gynecol. 2011 Aug;118(2 Pt 1):280-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21775843</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Oncol (Dordr). 2016 Jun;39(3):195-210</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27007278</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2011 Jan;120(1):113-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21056906</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Oncol (Dordr). 2015 Feb;38(1):3-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25586691</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2016 Jul;142(1):190-198</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27079213</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Mutat. 2017 Feb;38(2):226-235</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27767231</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Huazhong Univ Sci Technolog Med Sci. 2011 Aug;31(4):543-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21823019</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Algérie</li>
<li>Maroc</li>
<li>Pakistan</li>
</country>
<region><li>Rabat-Salé-Kénitra</li>
</region>
<settlement><li>Rabat</li>
</settlement>
</list>
<tree><country name="Maroc"><noRegion><name sortKey="El Bairi, Khalid" sort="El Bairi, Khalid" uniqKey="El Bairi K" first="Khalid" last="El Bairi">Khalid El Bairi</name>
</noRegion>
<name sortKey="Afqir, Said" sort="Afqir, Said" uniqKey="Afqir S" first="Said" last="Afqir">Said Afqir</name>
<name sortKey="Amrani, Mariam" sort="Amrani, Mariam" uniqKey="Amrani M" first="Mariam" last="Amrani">Mariam Amrani</name>
<name sortKey="El Bairi, Khalid" sort="El Bairi, Khalid" uniqKey="El Bairi K" first="Khalid" last="El Bairi">Khalid El Bairi</name>
<name sortKey="Louanjli, Noureddine" sort="Louanjli, Noureddine" uniqKey="Louanjli N" first="Noureddine" last="Louanjli">Noureddine Louanjli</name>
<name sortKey="Mahfoud, Wafaa" sort="Mahfoud, Wafaa" uniqKey="Mahfoud W" first="Wafaa" last="Mahfoud">Wafaa Mahfoud</name>
<name sortKey="Saadani, Brahim" sort="Saadani, Brahim" uniqKey="Saadani B" first="Brahim" last="Saadani">Brahim Saadani</name>
</country>
<country name="Pakistan"><noRegion><name sortKey="Kandhro, Abdul Hafeez" sort="Kandhro, Abdul Hafeez" uniqKey="Kandhro A" first="Abdul Hafeez" last="Kandhro">Abdul Hafeez Kandhro</name>
</noRegion>
</country>
<country name="Algérie"><noRegion><name sortKey="Gouri, Adel" sort="Gouri, Adel" uniqKey="Gouri A" first="Adel" last="Gouri">Adel Gouri</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/MaghrebDataLibMedV2/Data/Main/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000358 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000358 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    MaghrebDataLibMedV2
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:27981507
   |texte=   Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i   -Sk "pubmed:27981507" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MaghrebDataLibMedV2

This area was generated with Dilib version V0.6.38.
Data generation: Wed Jun 30 18:27:05 2021. Site generation: Wed Jun 30 18:34:21 2021

	Serveur sur les données et bibliothèques médicales au Maghreb (version finale)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur sur les données et bibliothèques médicales au Maghreb (version finale)

Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki